HealthcareServices

Cancer Stem Cells Industry Forecast to Hit $4.82 Billion by 2029 With a Strong 10.4% CAGR

November 20, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Cancer Stem Cells Market?

The cancer stem cells market size has seen substantial growth in recent years. It is anticipated to increase from $2.93 billion in 2024 to $3.24 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 10.8%. This historical expansion can be attributed to several factors, including a rise in funding for stemness pathway research, the widespread adoption of flow cytometry and cell sorting capabilities in academic centers, the integration of cancer stem cell endpoints in preclinical oncology studies, the development of niche and microenvironment investigations, and a surge in publications concerning cancer stem cell biology and therapy resistance mechanisms.

The cancer stem cells market size is anticipated to experience rapid growth in the coming years, reaching $4.82 billion by 2029 at a compound annual growth rate (CAGR) of 10.4%. This expansion during the forecast period is primarily driven by the increasing application of comprehensive genomic profiling and whole transcriptome analysis in hospitals, the growing demand for minimal residual disease monitoring in solid and blood cancers, the wider adoption of circulating tumor cell and circulating tumor deoxyribonucleic acid testing, the scale-up of single-cell sequencing and proteomics in clinical research networks, and the rising prevalence of therapy-resistant and relapsed cancer cases. Key trends in the forecast period are expected to include the integration of single-cell multimaps combining genomics, transcriptomics, proteomics, and epigenomics; the identification of rare tumor-initiating cells assisted by artificial intelligence and machine learning; microfluidics-based gentle cell sorting and closed system sample handling; organoid and tumoroid co-culture models incorporating immune and stromal components; and the spatial transcriptomics and spatial proteomics mapping of stemness niches.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27235&type=smp

Which Drivers Are Impacting The Cancer Stem Cells Market?

The future expansion of the cancer stem cells market is anticipated to be driven by the increasing need for personalized medicine. This refers to therapeutic strategies specifically crafted from a patient’s genetic profile, tumor characteristics, and individual reactions to ensure greater efficacy and fewer adverse effects. The growing adoption of personalized medicine is fueled by accessible genomic sequencing technologies, which are becoming more economical and extensively utilized in both oncology research and patient treatment. Personalized medicine effectively targets cancer stem cells (CSCs) by customizing treatments to match the unique molecular and genetic traits of a patient’s tumor. Initial analysis of tumors identifies mutations, signaling pathways, and surface markers specific to their CSC population, enabling healthcare providers to choose treatments that block essential pathways. For instance, in February 2024, data from the Personalized Medicine Coalition, a US-based hospital and health care organization, indicated that the Food and Drug Administration (FDA) sanctioned 16 new personalized treatments for rare disease patients in 2023, an increase from six in 2022. Therefore, the increasing need for real-time risk evaluation and prevention measures is propelling the expansion of the cancer stem cells market.

What Are The Major Segment Types Covered In The Cancer Stem Cells Market?

The cancer stem cells market covered in this report is segmented

1) By Type: Solid Tumor Stem Cells, Hematopoietic Stem Cells, Breast Cancer Stem Cells, Colorectal Cancer Stem Cells, Brain Cancer Stem Cells, Leukemia Stem Cells

2) By Cancer Forms: Breast, Blood, Lung, Brain, Colorectal, Pancreatic, Bladder, Liver, Other Cancer Forms

3) By Mode Of Action: Targeted Cancerous Stem Cells (Cscs), Stem Cell-Based Cancer Therapy

4) By Research Type: Basic Research, Clinical Research, Preclinical Research, Translational Research

5) By End User: Pharmaceutical And Biotechnology Companies, Research And Academic Institutions, Hospitals And Laboratories, Contract Research Organizations (CROs)

Subsegments

1) By Solid Tumor Stem Cells: Lung Cancer Stem Cells, Liver Cancer Stem Cells, Pancreatic Cancer Stem Cells, Prostate Cancer Stem Cells, Ovarian Cancer Stem Cells

2) By Hematopoietic Stem Cells: Myeloid Stem Cells, Lymphoid Stem Cells, Erythroid Stem Cells, Megakaryocytic Stem Cells, Granulocytic Stem Cells

3) By Breast Cancer Stem Cells: Triple Negative Breast Cancer Stem Cells, Hormone Receptor Positive Breast Cancer Stem Cells, Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer Stem Cells, Metastatic Breast Cancer Stem Cells, Inflammatory Breast Cancer Stem Cells

4) By Colorectal Cancer Stem Cells: Adenocarcinoma Colorectal Cancer Stem Cells, Mucinous Colorectal Cancer Stem Cells, Signet Ring Cell Colorectal Cancer Stem Cells, Metastatic Colorectal Cancer Stem Cells, Serrated Colorectal Cancer Stem Cells

5) By Brain Cancer Stem Cells: Glioblastoma Stem Cells, Medulloblastoma Stem Cells, Astrocytoma Stem Cells, Oligodendroglioma Stem Cells, Ependymoma Stem Cells

6) By Leukemia Stem Cells: Acute Myeloid Leukemia Stem Cells, Chronic Myeloid Leukemia Stem Cells, Acute Lymphoblastic Leukemia Stem Cells, Chronic Lymphocytic Leukemia Stem Cells, Mixed Phenotype Acute Leukemia Stem Cells

Which Trends Are Impacting The Cancer Stem Cells Market?

Major companies engaged in the cancer stem cells market are emphasizing technological advancements, such as pre-analytical immunomagnetic sorting systems, to optimize cell enrichment for enhanced diagnostic precision. Pre-analytical immunomagnetic sorting systems are sophisticated instruments that utilize magnetic particles coated with antibodies to precisely isolate specific cancer stem cell populations from complex biological samples, thereby improving the sensitivity and reproducibility of downstream assays. As an example, in March 2024, STEMCELL Technologies, a Canada-based biotechnology company, introduced the EasySep Human Bone Marrow CD138 Positive Selection Kit. This kit is notable as the first hematopoietic cell enrichment product to obtain FDA de novo classification as a Class II in vitro diagnostic device. It functions by enriching CD138+ plasma cells from bone marrow samples to improve the identification of multiple myeloma-related abnormalities. The product guarantees elevated sensitivity, reproducibility, and diagnostic accuracy, ultimately contributing to better patient outcomes in multiple myeloma care. The core purpose of this product is to fortify the pre-analytical phase of cancer diagnostics by supplying high-purity cell populations, which enables more reliable subsequent testing.

Who Are The Key Multinational Companies Dominating The Cancer Stem Cells Market?

Major companies operating in the cancer stem cells market are MacroGenics Inc., Novartis AG, Bristol-Myers Squibb Company, Eli Lilly and Company, Amgen Inc., Lonza Group AG, A. Menarini Industrie Farmaceutiche Riunite S.r.l., Bio-Techne Corporation, Zymeworks Inc., Kura Oncology Inc., GeneTex Inc., YZY Biopharma Co. Ltd., Abnova (Taiwan) Corporation, BioView Ltd., ScienCell Research Laboratories Inc., Boster Biological Technology Co. Ltd., BioFluidica Inc., AAT Bioquest Inc., Celprogen Inc., Actinium Pharmaceuticals Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/cancer-stem-cells-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Cancer Stem Cells Market?

North America was the largest region in the cancer stem cells market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer stem cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Cancer Stem Cells Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27235&type=smp

Browse Through More Reports Similar to the Global Cancer Stem Cells Market 2025, By The Business Research Company

Hydraulic Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hydraulic-equipment-global-market-report

Hydraulics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hydraulics-global-market-report

Smart Elevators Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/smart-elevators-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795